Low expressions of TPT1/TCTP and SETDB1 are correlated in leading to a better prognosis of breast cancer and colon cancer patients, respectively, which supports clinical benefits of the IO relationship normalization.[43, 60]. The gene discussed is SETDB1; the disease is breast carcinoma.